Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors-Reference-Cited by-同舟云学术

Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors

Published:2018-06 Issue: Volume:154 Page:29-43
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

OuYang Yiqiang,Zou Wensheng,Peng Liang,Yang Zunhua,Tang Qidong,Chen Mengzi,Jia Shuang,Zhang Hong,Lan Zhou,Zheng Pengwu,Zhu Wufu^ORCID

Funder

National Natural Science Funds of China

Natural Science Foundation of Jiangxi, China

Jiangxi Science & Technology Normal University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference13 articles.

1. Cardiorespiratory fitness, physical activity and cancer mortality in men;Vainshelboim;Prev. Med.,2017

2. The role of downstream signaling pathways of the epidermal growth factor receptor for artesunates activity in cancer cells;Konkimalla;Curr. Cancer Drug Targets,2009

3. Combination of epidermal growth factor receptor inhibitors and antiangiogenic drugs: a model for treatment;Martinelli;Targeted Oncol.,2006

4. A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway;Han;Oncotarget,2017

5. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations;Sequist;Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10

2. In Silico Exploration of Novel EGFR Kinase Mutant-Selective Inhibitors Using a Hybrid Computational Approach;Pharmaceuticals;2024-08-23

3. LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway;Medical Oncology;2023-07-31

4. Structure–Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017–Present);Pharmaceuticals;2023-04-03

5. Development of machine learning classifiers to predict compound activity on prostate cancer cell lines;Journal of Cheminformatics;2022-11-08